Luke J. Albrecht serves as the General Counsel and Secretary at Syndax Pharmaceuticals Inc., a biopharmaceutical company focused on developing therapies for various cancers. In his role, Albrecht is responsible for overseeing all legal matters within the company, including corporate governance, intellectual property, and compliance. His strategic legal guidance has been instrumental in navigating the complex regulatory landscape of the pharmaceutical industry, ensuring that Syndax remains at the forefront of innovation and patient care. Prior to joining Syndax, Albrecht held several key positions that have shaped his expertise in the biotech and pharmaceutical sectors. He previously worked as a senior attorney at a leading law firm, where he specialized in life sciences and healthcare law. During his tenure, he advised numerous biotech startups and established pharmaceutical companies on a wide range of legal issues, from mergers and acquisitions to licensing agreements. Albrecht's deep understanding of the industry, combined with his legal acumen, has enabled him to effectively support Syndax's mission to bring groundbreaking therapies to market. Albrecht's achievements extend beyond his professional role at Syndax. He is an active member of several professional organizations, including the American Bar Association and the Biotechnology Innovation Organization, where he contributes to discussions on the future of healthcare law and policy. His commitment to excellence and innovation has not only strengthened Syndax's legal framework but also positioned the company as a leader in the development of novel cancer treatments.